Search for: "Bristol-Myers Squibb Co. v. Teva Pharmaceuticals USA, Inc."
Results 1 - 18
of 18
Sorted by Relevance
|
Sort by Date
1 Jul 2014, 10:00 pm
In Bristol-Myers Squibb Co. v. [read post]
18 Dec 2009, 9:59 am
12/2: Bristol-Myers Squibb Company, Bristol-Myers Squibb Company, Novartis Corporation, et al. v. [read post]
24 Jul 2012, 8:09 am
Bristol-Myers Squibb Co. v. [read post]
24 Jul 2012, 8:18 am
Bristol-Myers Squibb Co. v. [read post]
28 Aug 2009, 8:11 am
(patent infringement) 8/28: Bristol-Myers Squibb Co., Bristol-Myers Squibb Pharma Co. v. [read post]
28 Sep 2010, 3:14 pm
Teva Pharmaceuticals USA Inc. et al. [read post]
17 Jul 2017, 9:41 am
Cir. 2012);see also Bristol-Myers Squibb Co. v. [read post]
9 Dec 2009, 3:59 pm
Teva Pharmaceuticals USA Inc. [read post]
24 Mar 2010, 4:45 am
(Patent Docs) Reyataz (Atazanavir): US: Patent infringement complaint filed following a Paragraph IV certification: Bristol-Myers Squibb Co. et al. v. [read post]
7 Nov 2014, 5:52 am
Teva Pharmaceuticals USA, Inc., 819 F. [read post]
21 Oct 2014, 9:03 am
In Bristol-Myers Squibb Company v. [read post]
12 Jun 2014, 10:41 am
Teva Pharmaceuticals USA, Inc. [read post]
2 Jun 2011, 12:46 pm
Squibb & Sons, Inc. v. [read post]
18 Jul 2014, 11:55 am
Teva Pharmaceuticals USA, Inc., 2010 WL 2640170, at *2 (W.D. [read post]
9 Aug 2012, 5:00 am
Bristol-Myers Squibb (?) [read post]
2 Mar 2012, 6:52 am
Bristol-Myers Squibb (?) [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case;… [read post]
19 Sep 2008, 6:00 pm
: (IP finance), United States: An open letter for the General Counsel of the PTO on your San Diego presentation next week: (Hal Wegner), United States: Cocoa genome: breaking intellectual property barriers: (Thomson Reuters Scientific), Vietnam: Patentability of second medical use claims in Vietnam is again questionable: (Trung Truc JSC) Pharma & Biotech - Products Allegra (Fexofenadine) - Canada: Motion for summary judgment of noninfringement dismissed in patent infringement… [read post]